PharmChem, Inc.
PCHM · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 3.8% | -3.3% | 2.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 64.2% | 63.9% | 64.6% | 65.2% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 23.3% | 26.4% | 28.6% | 44% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.2% | 19.6% | 22.4% | 37.1% |
| EPS Diluted | 0.059 | 0.064 | 0.076 | 0.12 |
| % Growth | -8.4% | -15.3% | -36.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |